Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ
Brain-targeting delivery of 1,1'-methylenebis[4-[(hydroxyimino)methyl]-pyridinium] dimethanesulfonate (MMB4 DMS) is limited by its hydrophilic property and chemical instability. In order to solve this problem, herein, we develop a facile protocol through combining antisolvent precipitation and...
Saved in:
Main Authors: | Yimeng Du (Author), Jing Gao (Author), Hui Zhang (Author), Xiaohui Meng (Author), Dong Qiu (Author), Xiang Gao (Author), Aiping Zheng (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malignant myoepithelioma of the breast (MMB); An interesting case report with pathological, immunohistochemical findings and review of literature
by: Ola A. Harb, et al.
Published: (2019) -
Size, shape, charge and "stealthy" surface: Carrier properties affect the drug circulation time in vivo
by: Jinwei Di, et al.
Published: (2021) -
DMS est en deuil...
Published: (2018) -
Aux collaborateurs de DMS
by: Martine Vidal, et al.
Published: (2013) -
Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine
by: Guanting Li, et al.
Published: (2023)